HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Kevin Baird Selected Research

Vivax Malaria

1/2022African Plasmodium vivax malaria improbably rare or benign.
10/2021The global burden of Plasmodium vivax malaria is obscure and insidious.
1/2021Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
1/2021Basic Research of Plasmodium vivax Biology Enabling Its Management as a Clinical and Public Health Problem.
7/2020Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial.
2/2020Corrigendum to: Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
10/2019Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
10/2019The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis.
8/2019Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
1/2019Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Kevin Baird Research Topics

Disease

52Malaria
01/2021 - 02/2002
36Vivax Malaria
01/2022 - 10/2002
19Glucosephosphate Dehydrogenase Deficiency
01/2021 - 11/2004
15Infections
01/2021 - 07/2002
7Hemolytic Anemia
01/2021 - 01/2013
7Parasitemia
12/2015 - 03/2002
7Falciparum Malaria (Plasmodium falciparum Malaria)
12/2015 - 10/2002
6Hemolysis
01/2021 - 01/2011
1Reticulocytosis
01/2021
1Reinfection
01/2018
1Acute malaria
12/2015
1Inborn Genetic Diseases (Disease, Hereditary)
11/2013
1Coma (Comas)
05/2012
1Hyperglycemia
09/2010
1Diabetes Mellitus
09/2010
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2009
1Vomiting
02/2007
1Diarrhea
02/2007
1Confusion (Bewilderment)
11/2004
1Methemoglobinemia
12/2003
1Anemia
03/2002

Drug/Important Bio-Agent (IBA)

43PrimaquineFDA Link
01/2021 - 06/2002
19Chloroquine (Aralen)FDA LinkGeneric
07/2020 - 03/2002
16Pharmaceutical PreparationsIBA
01/2019 - 03/2002
15Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
01/2021 - 03/2003
7tafenoquineIBA
01/2021 - 03/2003
6EnzymesIBA
01/2021 - 02/2002
58-aminoquinolineIBA
01/2021 - 03/2003
4piperaquineIBA
01/2021 - 03/2013
4artenimol (dihydroartemisinin)IBA
01/2021 - 03/2013
3Mefloquine (Lariam)FDA LinkGeneric
01/2021 - 04/2006
3artemisinin (artemisinine)IBA
07/2020 - 12/2015
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
08/2019 - 12/2014
3Cytochrome P-450 CYP2D6 (CYP2D6)IBA
08/2019 - 01/2018
3Antimalarials (Antimalarial Agents)IBA
01/2019 - 10/2002
2Biological ProductsIBA
10/2021 - 12/2002
2InsecticidesIBA
01/2013 - 11/2006
2AntibodiesIBA
10/2008 - 03/2006
2ImmunosorbentsIBA
10/2008 - 02/2002
2Hemoglobins (Hemoglobin)IBA
02/2007 - 03/2002
2proguanil drug combination atovaquone (malarone)FDA Link
11/2002 - 10/2002
1Blood Group Antigens (Blood Groups)IBA
01/2022
1Pheromones (Semiochemicals)IBA
10/2020
1Oxidoreductases (Dehydrogenase)IBA
10/2018
1Phosphates (Orthophosphate)IBA
10/2018
1Dextromethorphan (Racemethorphan)FDA LinkGeneric
01/2018
1DextrorphanIBA
01/2018
1Glucose-6-PhosphateIBA
01/2017
1glucose-6-phosphate dehydrogenase A-IBA
02/2016
1CopperIBA
06/2015
1SuspensionsIBA
06/2015
1Membrane Proteins (Integral Membrane Proteins)IBA
02/2015
1Doxycycline (Periostat)FDA LinkGeneric
12/2014
1(2,3,5,6- tetrafluoro- 4- methoxymethylphenyl)methyl- 2,2- dimethyl- 3- (1- propenyl)cyclopropanecarboxylateIBA
12/2014
1Quinine (Quinson)FDA Link
03/2013
1Lumefantrine Drug Combination Artemether (Coartem)FDA Link
07/2012
1Blood Glucose (Blood Sugar)IBA
05/2012
1SteroidsIBA
09/2010
1fibrin fragment D (D-dimer)IBA
09/2010
1Anti-Bacterial Agents (Antibiotics)IBA
11/2009
1Merozoite Surface Protein 1 (MSA1)IBA
10/2008
1ArtesunateIBA
05/2008
1Ro 21-5104IBA
02/2007
1Folic Acid AntagonistsIBA
02/2005
1Praziquantel (Biltricide)FDA Link
10/2004
1DNA (Deoxyribonucleic Acid)IBA
10/2003
1Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
07/2003
1desethylchloroquineIBA
04/2003
1VaccinesIBA
03/2002
1DDTIBA
03/2002
1Hepatitis B Surface Antigens (HBsAg)FDA Link
02/2002

Therapy/Procedure

42Therapeutics
01/2021 - 06/2002
8Chemoprevention
01/2021 - 03/2003
3Drug Therapy (Chemotherapy)
01/2021 - 07/2009
3Transcutaneous Electric Nerve Stimulation (TENS)
12/2016 - 06/2015
1Secondary Prevention
01/2013